TY - JOUR
T1 - Molecular cloning and expression analysis of a novel gene DGCR8 located in the DiGeorge syndrome chromosomal region
AU - Shiohama, Aiko
AU - Sasaki, Takashi
AU - Noda, Setsuko
AU - Minoshima, Shinsei
AU - Shimizu, Nobuyoshi
N1 - Funding Information:
The authors thank Harumi Harigai for her help in preparing the manuscript. This work was supported by a Fund for “Research for the Future” Program from the Japan Society for the Promotion of Science and a Grant-in-Aid for Scientific Research on Priority Areas “Medical Genome Science” from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). A.S. is a recipient of the fellowship supported by “21st Century Center of Excellence (COE) Program” from MEXT.
PY - 2003/4/25
Y1 - 2003/4/25
N2 - We have identified and cloned a novel gene (DGCR8) from the human chromosome 22q11.2. This gene is located in the DiGeorge syndrome chromosomal region (DGCR). It consists of 14 exons spanning over 35kb and produces transcripts with ORF of 2322bp, encoding a protein of 773 amino acids. We also isolated a mouse ortholog Dgcr8 and found it has 95.3% identity with human DGCR8 at the amino acid sequence level. Northern blot analysis of human and mouse tissues from adult and fetus showed rather ubiquitous expression. However, the in situ hybridization of mouse embryos revealed that mouse Dgcr8 transcripts are localized in neuroepithelium of primary brain, limb bud, vessels, thymus, and around the palate during the developmental stages of embryos. The expression profile of Dgcr8 in developing mouse embryos is consistent with the clinical phenotypes including congenital heart defects and palate clefts associated with DiGeorge syndrome (DGS)/conotruncal anomaly face syndrome (CAFS)/velocardiofacial syndrome (VCFS), which are caused by monoallelic microdeletion of chromosome 22q11.2.
AB - We have identified and cloned a novel gene (DGCR8) from the human chromosome 22q11.2. This gene is located in the DiGeorge syndrome chromosomal region (DGCR). It consists of 14 exons spanning over 35kb and produces transcripts with ORF of 2322bp, encoding a protein of 773 amino acids. We also isolated a mouse ortholog Dgcr8 and found it has 95.3% identity with human DGCR8 at the amino acid sequence level. Northern blot analysis of human and mouse tissues from adult and fetus showed rather ubiquitous expression. However, the in situ hybridization of mouse embryos revealed that mouse Dgcr8 transcripts are localized in neuroepithelium of primary brain, limb bud, vessels, thymus, and around the palate during the developmental stages of embryos. The expression profile of Dgcr8 in developing mouse embryos is consistent with the clinical phenotypes including congenital heart defects and palate clefts associated with DiGeorge syndrome (DGS)/conotruncal anomaly face syndrome (CAFS)/velocardiofacial syndrome (VCFS), which are caused by monoallelic microdeletion of chromosome 22q11.2.
KW - 22q11.2
KW - Conotruncal anomaly face syndrome
KW - DGCR8
KW - DiGeorge syndrome
KW - DiGeorge syndrome chromosomal region
KW - Expression analysis
KW - Gene structure
KW - Genome sequencing
KW - Velocardiofacial syndrome
UR - http://www.scopus.com/inward/record.url?scp=0037466486&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037466486&partnerID=8YFLogxK
U2 - 10.1016/S0006-291X(03)00554-0
DO - 10.1016/S0006-291X(03)00554-0
M3 - Article
C2 - 12705904
AN - SCOPUS:0037466486
SN - 0006-291X
VL - 304
SP - 184
EP - 190
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 1
ER -